Vertex rejoint le programme ISV Accelerator d’Oracle, conçu pour les solutions logicielles sous forme d’abonnement, ou SaaS pour Software as a Service
April 24, 2024 17:48 ET
|
Vertex Inc.
KING OF PRUSSIA, Pennsylvanie, 24 avr. 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ : VERX), ci-après « Vertex » ou « la société », fournisseur mondial de technologies fiscales et membre d’Oracle...
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
April 24, 2024 16:01 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
Glioma Pipeline Landscape Report 2024: Comprehensive Market Insights on 180+ Companies and Respective 200+ Pipeline Drugs
April 24, 2024 11:36 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Glioma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Glioma - Pipeline Insight, 2024" report...
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate
April 24, 2024 10:31 ET
|
Class 1 Nickel and Technologies Limited
Indicated Resources (open pit and underground*) of 572 kt at 0.61% Ni (7.7M lbs Ni) – 44% increase in Indicated tonnes and 10% increase in nickel pounds.Inferred Resources (open pit and underground*)...
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 10:01 ET
|
Cue Biopharma, Inc.
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 10:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts...
Application Security Innovator Backslash Identifies AI-Generated Code Concerns via OSS Reachability Analysis, Phantom Package Visibility Capabilities
April 24, 2024 09:00 ET
|
Backslash Security
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Backslash Security, a modern application security solution that leverages deep reachability analysis for enterprise AppSec and product security...
Bridgetown Mushrooms Proudly Partners with RPG Coffee and Kindness.org to Launch Kind Coffee Cooperative™— Promoting Wellness and Fostering Kindness
April 24, 2024 09:00 ET
|
Bridgetown Mushrooms
PORTLAND, Ore., April 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Bridgetown Mushrooms, renowned for its commitment to organic farming and sustainable practices, is thrilled to announce its partnership...
Global Medical Plastics Strategic Research Report 2024: Market to Surpass $50 Billion by 2030 - Plastics in Healthcare Pioneering New Frontiers in Medical Device Evolution
April 24, 2024 08:52 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Medical Plastics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Medical Plastics Market to...
Vertex Selected to Join Oracle ISV Accelerator for SaaS Initiative
April 24, 2024 08:00 ET
|
Vertex Inc.
KING OF PRUSSIA, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions and a member of Oracle PartnerNetwork...